Hainan Shuangcheng Pharmaceuticals Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 113.857 million compared to CNY 177.804 million a year ago. Operating loss was CNY 27.441 million compared to CNY 26.424 million a year ago. Net loss was CNY 17.054 million compared to CNY 14.560 million a year ago. Basic loss per share from continuing operations was CNY 0.04 compared to CNY 0.04 a year ago.